Condition 1: Overweight. Condition 2: Vitamin D deficiency. Obesity due to excess calories Vitamin D deficiency
Conditions
Interventions
Intervention 1: Control group: There is no intervention in the control group and they are given placebo in a single blind manner. Intervention 2: Intervention group 1: Vitamin D group, who take 50,000
Sponsors
Sari branch, Islamic Azad University
Eligibility
Sex/Gender
Female
Age
23 Years to 29 Years
Inclusion criteria
Inclusion criteria: Having a body mass index between 25 to 29 kg / m2 Not participating in regular sports activities for the past six months Not having cardiovascular disease Not having hypertension Not having Inflammatory diseases Serum levels of 25-hydroxyvitamin D less than 30 ng / ml
Exclusion criteria
Exclusion criteria: Use any specific medications or supplements Pregnancy Smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eotaxin-1. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Sirtuin1. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Interlukin10. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;25- hydroxy vitamin D. Timepoint: Before and after interventions. Method of measurement: Using the ELISA method.;Brain-Derived Neurotrophic Factor. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Superoxide dismutase. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Laboratory methods.;Tumor necrosis factor alpha. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Monocyte Chemoattractant Protein 1. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Malondialdehyde. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: spectrophotometrically.;Homocysteine. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Total Antioxidant Capacity. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Ferric Reducing/Antioxidant Power.;Transforming growth factor-beta 1 (TGF-beta1). Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Vascular endothelial growth factor (VEGF). Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;C-Reactive Protein (CRP). Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Using the ELISA method.;Adiponectin. T | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Before and after interventions. Method of measurement: Sleep quality questionnaire.;Quality of Life. Timepoint: Before the intervention and 2 weeks after the intervention. Method of measurement: Quality of Life Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh habibian
Qaemshahr branch, Islamic Azad University
Outcome results
None listed